|
ARSB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.49060000004453E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.05350000000482E-05 |
| Normal-vs-Stage2 |
4.242500E-03 |
| Normal-vs-Stage3 |
2.826200E-04 |
| Normal-vs-Stage4 |
7.295600E-03 |
| Stage1-vs-Stage2 |
7.347600E-01 |
| Stage1-vs-Stage3 |
4.851800E-01 |
| Stage1-vs-Stage4 |
7.080000E-01 |
| Stage2-vs-Stage3 |
8.680400E-01 |
| Stage2-vs-Stage4 |
9.789400E-01 |
| Stage3-vs-Stage4 |
8.933200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.6256999997627E-07 |
| Normal-vs-AfricanAmerican |
1.252000E-02 |
| Normal-vs-Asian |
1.708160E-01 |
| Caucasian-vs-AfricanAmerican |
5.936600E-01 |
| Caucasian-vs-Asian |
6.946500E-02 |
| AfricanAmerican-vs-Asian |
9.314400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.989200E-04 |
| Normal-vs-Female |
1.51662999999802E-05 |
| Male-vs-Female |
9.073600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.832300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.396430E-03 |
| Normal-vs-Age(61-80Yrs) |
4.45829999999869E-05 |
| Normal-vs-Age(81-100Yrs) |
6.24779999999214E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.117000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.403400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.295180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.210200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.076000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.357200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.116400E-01 |
| Classical-VS-Follicular |
3.193700E-02 |
| Classical-VS-Other |
1.238990E-01 |
| Classical-VS-Normal |
3.30590000041653E-07 |
| Tall-VS-Follicular |
1.320220E-01 |
| Tall-VS-Other |
8.279800E-02 |
| Tall-VS-Normal |
2.742600E-03 |
| Follicular-VS-Other |
4.082200E-01 |
| Follicular-VS-Normal |
4.952200E-02 |
| Other-VS-Normal |
8.763800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.979600E-04 |
| Normal-vs-N1 |
5.537800E-02 |
| N0-vs-N1 |
8.538000E-01 |
|
|
